A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis

Abstract

Our findings highlight a gene and corresponding protein signature with effective capacity for identification of stage-I lung adenocarcinoma patients with poor prognosis that are likely to benefit from adjuvant therapy.